BioSpace News Archive

Provention Bio, Inc. announced the European Medicines Agency has granted PRV-031 PRIority MEdicines designation for the prevention or delay of clinical type 1 diabetes in individuals at-risk of developing the disease.

ADVANZ PHARMA Corp. announced it intends to release its third quarter, 2019 financial results before market open on Thursday, November 7, 2019..

First Four “Process A” Patients Demonstrate Long-Term Evidence of Increasing and Durable Engraftment Resembling FA Mosaic Patients

Replimune Group Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, announced that the company has enrolled the first patient in its Phase 1 clinical trial of RP2.

iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter and nine-months ended September 30, 2019, before the market open, and host a conference call at 8:30am Eastern Time on Wednesday, October 30, 2019.

Oral presentations by Jill Waibel, MD and Ashish Bhatia, MD

Expanded footprint gives 4 out of 5 Medicare-eligible beneficiaries access to an Aetna Medicare Advantage plan

Compass Therapeutics, a clinical-stage biotechnology company focused on drugging the human immune synapse to treat human diseases, today announced two upcoming poster presentations at the Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting, which is being held November 6-10 in National Harbor, MD.

Amicus Therapeutics announced additional positive interim results from its CLN6 Batten disease gene therapy program licensed from the Abigail Wexner Research Institute at Nationwide Children’s Hospital.

Butterfly Network, makers of the world’s first single-probe whole body ultrasound system, Butterfly iQ, is now making it easier for hospitals and organizations to scale their point of care ultrasound programs through a new suite of tools making ultrasound workflow mobile, system integrations simple and security even more robust.